全文获取类型
收费全文 | 4668篇 |
免费 | 225篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 303篇 |
妇产科学 | 69篇 |
基础医学 | 559篇 |
口腔科学 | 165篇 |
临床医学 | 282篇 |
内科学 | 906篇 |
皮肤病学 | 137篇 |
神经病学 | 267篇 |
特种医学 | 143篇 |
外科学 | 628篇 |
综合类 | 110篇 |
一般理论 | 3篇 |
预防医学 | 226篇 |
眼科学 | 187篇 |
药学 | 626篇 |
中国医学 | 19篇 |
肿瘤学 | 261篇 |
出版年
2023年 | 19篇 |
2022年 | 69篇 |
2021年 | 138篇 |
2020年 | 69篇 |
2019年 | 93篇 |
2018年 | 122篇 |
2017年 | 97篇 |
2016年 | 98篇 |
2015年 | 103篇 |
2014年 | 180篇 |
2013年 | 216篇 |
2012年 | 331篇 |
2011年 | 364篇 |
2010年 | 181篇 |
2009年 | 177篇 |
2008年 | 272篇 |
2007年 | 286篇 |
2006年 | 232篇 |
2005年 | 224篇 |
2004年 | 204篇 |
2003年 | 174篇 |
2002年 | 149篇 |
2001年 | 114篇 |
2000年 | 102篇 |
1999年 | 85篇 |
1998年 | 32篇 |
1997年 | 39篇 |
1996年 | 23篇 |
1995年 | 18篇 |
1994年 | 14篇 |
1993年 | 19篇 |
1992年 | 69篇 |
1991年 | 57篇 |
1990年 | 59篇 |
1989年 | 53篇 |
1988年 | 47篇 |
1987年 | 42篇 |
1986年 | 53篇 |
1985年 | 38篇 |
1984年 | 27篇 |
1983年 | 22篇 |
1981年 | 14篇 |
1980年 | 10篇 |
1979年 | 16篇 |
1977年 | 16篇 |
1976年 | 11篇 |
1974年 | 17篇 |
1973年 | 19篇 |
1972年 | 15篇 |
1969年 | 10篇 |
排序方式: 共有4910条查询结果,搜索用时 25 毫秒
91.
Promadej N Costello C Wernett MM Kulkarni PS Robison VA Nelson KE Hodge TW Suriyanon V Duerr A McNicholl JM 《The Journal of infectious diseases》2003,187(7):1053-1063
Eighteen highly exposed but persistently seronegative (HEPS) women (HW) and their human immunodeficiency virus (HIV) type 1-seropositive male partners were studied for HIV-specific T cells and other host factors. Circulating HIV-specific T cells were measured by interferon-gamma enzyme-linked immunospot assays, using recombinant vaccinia virus vectors expressing HIV proteins. Nine (50%) of the HW and all HIV-seropositive persons had HIV-specific T cell responses. Only 2 (22%) of the HEPS responders recognized Env, compared with 94% of HIV-seropositive persons. A high percentage (75%) of the HW with HIV-specific T cell responses reported recent HIV exposure. Remarkably, however, long-lived HIV-specific T cells were detected in 2 HW who had an extended period (>3.9 years) of no HIV exposure. These findings have important implications for HIV vaccine design. 相似文献
92.
Mehta J Powles R Sirohi B Treleaven J Swansbury GJ Kulkarni S Saso R Singhal S 《Bone marrow transplantation》2003,32(2):157-164
A total of 81 adults with acute myeloid leukemia (AML) (47% favorable karyotypes) were autografted in first remission after melphalan-total body irradiation, having received 0 (n=7), 1 (n=19), 2 (n=51), or 3 (n=4) consolidation chemotherapy cycles before harvest. The cumulative 5-year incidences of relapse and transplant-related mortality were 37 and 17%, respectively. The actuarial 5-year probability of disease-free survival (DFS) was 46%. In Cox analysis, favorable karyotypes, increasing numbers of consolidation cycles (0 vs > or =1 or 1 vs >1), and higher nucleated cell doses were associated with lower relapse rates and higher DFS. Patients with favorable karyotypes benefited from every additional cycle of consolidation therapy (0 vs > or =1 as well as 1 vs >1). Among patients with other karyotypes, while the benefit of one cycle of consolidation was clear (0 vs > or =1), there was no obvious beneficial impact of further consolidation therapy (1 vs >1). Administration of consolidation chemotherapy prior to harvest is essential in AML. While it is possible to enhance the benefit of consolidation with favorable karyotypes by delivering two cycles, its usefulness is limited in others. In them, it may be worthwhile exploring alternatives not normally used in AML (eg high-dose cyclophosphamide) that could have antileukemic effects while permitting mobilization of stem cells. 相似文献
93.
R. K. Menda M.D. H. L. Chulani M.D. S. J. Yawalkar M.D. B. S. Kulkarni M.D. 《Diseases of the colon and rectum》1971,14(6):454-459
Summary Thirty cases of venereal and related anal affections seen at G. T. Hospital have been reviewed. Occupational factors in the
etiology of the disease, as well as other factors, have been stressed. Multiple fissures of the nonsyphilitic type were the
lesions most often encountered. The types of diseases seen and their treatment have been described. 相似文献
94.
Uday C. Ghoshal Deepakshi Srivastava Asha Misra 《Indian journal of gastroenterology》2018,37(5):416-423
Objective
Gut microbe-derived methane may slow colon transit causing chronic constipation (CC). Effect of rifaximin on breath methane and slow-transit CC was evaluated.Method
Bristol stool form, frequency, colon transit time (CTT), and breath methane were evaluated in 23 patients with CC (10 patients with constipation-predominant irritable bowel syndrome [IBS-C], 13 functional constipation, Rome III) and m-ethane production compared with 68 non-constipating IBS. Methane-producing CC (basal ≥?10 PPM and/or post-lactulose rise by >?10 PPM) was randomized (double-blind) to rifaximin (400-mg thrice/day, 2-weeks) or placebo. Stool forms, frequency, breath methane, and CTT were recorded afterward.Results
CC patients tended to be methane producer more often (13/23 [56.5%] vs. 25/68 [36.5%], p?=?0.07) and had greater area under curve (AUC) for methane (2415 [435–23,580] vs. 1335 [0–6562.5], p?=?0.02) than non-constipating IBS. Methane producers (8/13 [61.5%]) and 5/10 (50%) non-producers had abnormal CTT (marker retention: 36-h, 53 [0–60] vs. 19 [8–56], p?=?0.06; 60-h, 16 [0–57] vs. 13 [3–56], p?=?0.877). Six and 7/13 methane producers were randomized to rifaximin and placebo, respectively. Rifaximin reduced AUC for methane more (6697.5 [1777.5–23,580] vs. 2617.5 [562.5–19,867.5], p?=?0.005) than placebo (3945 [2415–12,952.5] vs. 3720 [502.5–9210], p?=?0.118) at 1 month. CTT normalized in 4/6 (66.7%) on rifaximin (36-h retention, 54 [44–57] vs. 36 [23–60], p?=?0.05; 60-h, 45 [3–57] vs. 14 [11–51], p?=?0.09) but none on placebo (p?=?0.02) (36-h, 31 [0–60] vs. 25 [0–45], p?=?0.078; 60-h, 6 [0–54] vs. 12 [0–28], p?=?0.2). Weekly stool frequency (3 [1–9] and 7 [1–14], p?=?0.05) and forms improved with rifaximin than placebo.Conclusion
Rifaximin improves CC by altering methane production and colon transit.Trial registration
Clinical Trial Registry, India: REF/2012/01/00321695.
Powles R Sirohi B Kulkarni S Treleaven J Rudin C Sankpal S Goyal S Horton C Millar B Saso R Singhal S Mehta J 《Bone marrow transplantation》2002,30(8):479-484
We have shown that primary therapy with non-myeloablative (140 mg/m(2)) high-dose melphalan (HDM) without hematopoietic support results in high response rates in untreated myeloma and very long-term survival of some patients. This study was designed to see if sufficient CD34 (+) cells can be harvested at presentation in newly diagnosed patients to administer myeloablative HDM (200 mg/m(2); HDM200) with autograft as primary therapy. This may improve outcome by rapid achievement of complete remission (CR) and possible avoidance of late myelodysplasia as a consequence of non-transplant induction chemotherapy. Thirty untreated patients received 1 g/m(2) methylprednisolone daily (days 1-6) and 12-16 micro g/kg G-CSF daily (days 3-6), and underwent leukapheresis on days 6 and 7. The median CD34(+) cell yield was 1.31 x10(6)/kg (range, 0.23-5.63), and was > or =1 x10(6)/kg in 73%. Cell yields were significantly lower than in 82 historical controls apheresed after completion of induction chemotherapy (median 2.16 x 10(6)/kg), and improved in patients who were apheresed again after induction chemotherapy. Three patients received primary therapy with HDM200 and autograft using these cells and attained CR. We conclude that it is possible to harvest stem cells in three-quarters of untreated myeloma patients. Increasing the number of apheresis procedures is needed to improve the number of CD34(+) cells collected. 相似文献
96.
Testicular metastasis presenting as a testicular mass is an extremely rare condition. There are only nine previously reported cases where testicular mass was the first clinical manifestation of underlying malignancy. Here we report a case of metastatic mucin secreting adenocarcinoma in testis presenting as a testicular mass with unknown primary. We have given a brief review of literature about the spread of tumor to testes. 相似文献
97.
Kulkarni S Powles RL Treleaven JG Singhal S Saso R Horton C Killick S Tait D Ramiah V Mehta J 《Bone marrow transplantation》1999,23(7):675-680
We describe a single centre experience of 33 patients allografted for multiple myeloma, of which 28 received matched sibling marrow, one haploidentical family donor marrow and four matched but unrelated donor marrow. Median follow-up after transplant is 27 months, and 13 patients are currently alive. One out of four patients with an unrelated donor survives and 12 out of 28 (42.8%) with matched sibling donors. Four patients were unevaluable because of early death (相似文献
98.
99.
Rao BL Yeolekar LR Kadam SS Pawar MS Kulkarni PB More BA Khude MR 《The Southeast Asian journal of tropical medicine and public health》2005,36(4):906-909
Influenza surveillance was conducted in Pune, India in 2003. A total of 573 throat swabs/ nasal swabs (TS/NS) and 190 nasopharyngeal aspirates (NPA) were collected from 763 in- and out-patients who were mostly children aged 0-16 years. TS/NS (507/573) and NPA (42/190) specimens were processed in MDCK cell cultures and identified with the hemagglutination inhibition test (HI). A total of 37 influenza viruses was isolated: twenty-three type A (H3N2) and 14 type B of the Yamagata lineage were isolated from 29 children and 8 adults. Three type A (H3N2) isolates were characterized as being similar to A/Panama/2007/99 like, A/Korea/770/2000 like, and B/Sichuan/379/99 like strains. 相似文献
100.
Spoorthy Kulkarni Raunak Rao James Delman Harry Goodman Kathleen Connolly Kevin M. O'Shaughnessy 《Medicine》2021,100(14)
Medication nonadherence represents a modifiable risk factor for patients with hypertension. Identification of nonadherent patients could have significant clinical and economic implications in the management of uncontrolled hypertension.We analysed the results of 174 urinary adherence screens from patients referred to Addenbrooke''s Hospital, Cambridge, for uncontrolled hypertension. Cases were identified for evaluation by results of liquid chromatography-tandem mass spectrometry of urine samples (males: 91; females: 83; age range: 17–87). We performed a binary logistic regression analysis for nonadherence using age, sex, and number of medications prescribed (both antihypertensives and non-antihypertensives separately) as independent predictors. Rates of nonadherence for individual antihypertensive drugs were calculated if prescribed to ≥10 patients.The overall rate of nonadherence to one or more prescribed antihypertensive medications was 40.3%. 14.4% of all patients were nonadherent to all prescribed antihypertensive medications (complete nonadherence), whereas 25.9% of all patients were nonadherent to at least 1, (but not all) prescribed antihypertensive medications (partial nonadherence). 72% of patients were prescribed ≥3 antihypertensives And for every increase in the number of antihypertensive medications prescribed, nonadherence increased with adjusted odds ratios of 2.9 (P < .001). Logistic regression showed that women were 3.3 times more likely to be nonadherent (P = .004). Polypharmacy (≥6 medications prescribed for hypertension and/or concomitant comorbidities) was prevalent in 52%. Bendroflumethiazide and chlortalidone demonstrated the highest and lowest nonadherences respectively (45.5% and 11.8%).Rate of nonadherence in patients with hypertension was significantly impacted by sex and number of antihypertensive medications prescribed. Understanding these factors is crucial in identifying and managing nonadherence. 相似文献